By Julie Steenhuysen, Siddhi Mahatole and Mariam Sunny May 1 (Reuters) - Moderna surpassed Wall Street estimates for first-quarter revenue on Friday, helped by better-than-expected sales of its ...
Australia has reached a supply agreement for 25 million doses of Moderna COVID-19 vaccines in a deal that the government hopes will ensure all Australian adults have access to inoculation this year.
Australia’s medicines regulator has confirmed it is evaluating a low dose for children as young as six-months-old.
Moderna reported positive Phase 3 results for its mRNA seasonal influenza vaccine candidate, mRNA-1010, showing stronger ...
Regulatory filings are under review in the U.S., Europe, Canada and Australia, with potential approvals expected to begin in ...
May 1 (Reuters) - Moderna surpassed Wall Street estimates for first-quarter revenue on Friday, helped by better-than-expected sales of its COVID-19 vaccine in international markets. The vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results